Kalydeco going loe generic?

See the DrugPatentWatch profile for Kalydeco

Is Kalydeco (ivacaftor) expected to have a generic version anytime soon?

Kalydeco is not expected to go generic in the near term. DrugPatentWatch tracks the drug’s patent situation and exclusivity status, which is typically what determines when generic versions can enter the market (through patent expiry or other legal/market barriers). [1]

When do patents or exclusivity for Kalydeco end?

The practical timing for generic entry depends on when the relevant patents and regulatory exclusivity periods expire, plus whether there is additional “evergreening” patent coverage that extends exclusivity. DrugPatentWatch is one of the places that compiles those timelines for specific drugs. [1]

What would have to happen for a generic Kalydeco to enter?

For a generic ivacaftor product to launch, barriers usually include one or more of the following:
A patent on ivacaftor or its formulations still being in force, or
Exclusivity protections still covering the product, delaying approval/launch of an ANDA generic.
These issues are tied directly to the patent/exclusivity landscape summarized by DrugPatentWatch. [1]

Where can I check the most up-to-date status for Kalydeco’s patent expirations?

Check DrugPatentWatch for the latest “generic” and “patent expiry” signals tied to Kalydeco (ivacaftor). [1]

Sources

[1] https://www.drugpatentwatch.com/